Dr. Wiep Scheper

Assistant Professor, VU Medical Centre, Amsterdam

Wiep Scheper obtained an MSc in Medical Biology (majors in Molecular Neurobiology and Molecular Biology, the latter at UMass, Worchester MA, USA) and PhD in Molecular Biology at the Faculty of Medicine, Utrecht University, the Netherlands. This fundamental training provided her with a strong foundation to pursue a career in unraveling molecular mechanisms in neurodegenerative disorders. After post-doctoral projects at the Academic Medical Centre (AMC) in Amsterdam, University of Leuven, Belgium and Cambridge University, UK she started her own research group at the AMC. Over the years the group has been studying the role of protein quality control in Alzheimer’s disease and other neurodegenerative diseases with a specific focus on the unfolded protein response, autophagy and tau pathology. The combination of analysis of human post-mortem brain material and functional cell studies has resulted in the key papers about the role of the UPR in neurodegeneration and established a firm position for the group in the field. Since August 2013 the group has moved to the VUmc/VU in Amsterdam, where the close interactions with neuropathology, Alzheimer Center and fundamental neuroscience further enhance the translational research line.
Dr. Scheper is editor of the Journal of Neurodegenerative Diseases and BioMed Research International and member of Scientific Advisory Board of the Internationale Stichting Alzheimer Onderzoek (International Foundation for Alzheimer’s Research).
Dr. Scheper has obtained several personal fellowships (Anton Meelmeijer Career development award, FEBS long-term fellowship, NWO-Meervoud fellowship) and her research has obtained funding throughout the years by ISAO, NWO, Hersenstichting, EU, Janssen pharmaceuticals, Alzheimer Nederland and ZonMW.

Dr. Wiep Scheper Grants